Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
The relationship between use of oral contraceptives and fibrocystic breast disease was examined in a hospital-based case-control study undertaken in New Haven, Connecticut, from 1977 to 1979. Particular emphasis was placed on the extent of epithelial atypia and other histopathologic characteristics found in the biopsy specimens from the cases. Women who had ever used oral contraceptives were at a somewhat decreased risk for fibrocystic disease as a whole. Cases with high atypia and controls had similar patterns of oral contraceptive use, whereas cases with low and intermediate atypia had less oral contraceptive use than controls. Cases with intermediate atypia reported the lowest oral contraceptive use. Subjects with biopsy specimens exhibiting gross cysts, microscopic cysts, or papillomatosis were about 50% less likely to have used oral contraceptives than controls.
D000328:Adult; D000368:Aged; D001835:Body Weight; D001941:Breast Diseases / Q000473:pathology*; D003237:Connecticut; D003276:Contraceptives, Oral / Q000009:adverse effects; D004812:Epidemiologic Methods; D005260:Female; D005348:Fibrocystic Breast Disease / Q000139:chemically induced / Q000473:pathology*; D006801:Humans; D008423:Maternal Age; D008875:Middle Aged; D010298:Parity; D012306:Risk; D013997:Time Factors
D003276:Contraceptives, Oral